Nisa Investment Advisors’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Nisa Investment Advisors’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,638	Closed	-$575K	–	2675
2022 Q2	$575K	Buy	7,638 +1,518	+25%	+$67.5K	0.01%	1004
2022 Q1	$164K	Sell	6,120 -7,730	-56%	-$260K	﹤0.01%	1459
2021 Q4	$516K	Buy	13,850 +11,500	+489%	+$514K	﹤0.01%	1003
2021 Q3	$156	Buy	2,350 +300	+15%	+$21.4K	﹤0.01%	1508
2021 Q2	$160	Buy	2,050 +700	+52%	+$51.7K	﹤0.01%	1489
2021 Q1	$128	Hold	1,350	–	–	﹤0.01%	1648
2020 Q4	$164K	Buy	1,350 +550	+69%	+$60.3K	﹤0.01%	1553
2020 Q3	$70K	Buy	+800	New	+$55.7K	﹤0.01%	1667

Nisa Investment Advisors's TPTX Position: Q3 2022 in Review

Nisa Investment Advisors sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 7,638 shares — an estimated $575K sold.

Nisa Investment Advisors first reported a position in TPTX in Q3 2020 and held it in 8 quarters. The position peaked at $575K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Nisa Investment Advisors reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Nisa Investment Advisors sold 7,638 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $575K.
Nisa Investment Advisors first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
Nisa Investment Advisors's Turning Point Therapeutics, Inc. Common Stock position peaked at $575K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Nisa Investment Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.